Home » Newsletters » BioWorld Science

BioWorld Science

March 9, 2010

View Archived Issues

PK/PD modeling of siltuximab predicts clinically feasible dosing regimen

Nycomed claims novel phosphodiesterase 5 inhibitors

BFPT-2603 safe and efficacious in monkey model of allergic asthma

Ulipristal noninferior to levonorgestrel for emergency contraception

Denosumab shows therapeutic activity in giant-cell tumor of bone

NicOx discloses novel nitric oxide-releasing steroids

Eisai discovers novel JNK3 kinase inhibitors

Dual M3 antagonists/beta2-adrenoceptor agonists claimed by Argenta and AstraZeneca

Genta raises funds for advancement Genasense and tesetaxel

Isis earns milestone payment from Bristol-Myers for BMS-PCSK9Rx

MDS Foundation comments on NICE's decision against Vidaza

Summit claims novel upregulators of endogenous utrophin

Roche and Biogen place ocrelizumab rheumatoid arthritis program on hold

Auxilium launches Xiaflex in U.S. for treatment of Dupuytren's contracture

Genmab reports phase III results on zalutumumab in refractory head and neck cancer

Nabi and GSK close NicVAX option and license agreement

Novavax completes enrollment in pivotal H1N1 flu vaccine trial

XenoPort to focus on key later-stage product candidates

FDA approves NDA for Alza's Exalgo for pain management

Nektar Therapeutics presents phase II data on NKTR-102 in platinum-resistant ovarian cancer

ExonHit and bioMerieux terminate colon cancer collaboration

Advaxis confirms long-term stability ADXS11-001 cancer vaccine

Mologen's phase II IMPACT trial of MGN-1703 in cancer approved in Germany and Austria

FDA and EMA grant orphan drug status to ImmunoGen's IMGN-901 in MCC

New neuraminidase inhibitor CS-8958 shows promise in preclinical and clinical evaluation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...